Abilify and Coq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Coq (coenzyme q - 10). Common drug interactions include crohn's disease among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Coq. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Coq?

Coq has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 11,465 Coq users. Check the latest studies of Coq.



On Jul, 09, 2026

62 people who take Abilify and Coq together, and have interactions are studied.

Abilify and Coq drug interactions.

What are the common drug interactions of Abilify and Coq, by gender? *:

female:

  1. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  2. Deafness
  3. Dehydration (dryness resulting from the removal of water)
  4. Dental caries
  5. Dry skin
  6. Dysarthria (speech disorder)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Dysphonia (speech disorder attributable to a disorder of phonation)
  9. Dysuria (painful or difficult urination)
  10. Ear infection

male:

  1. Insomnia (sleeplessness)
  2. Dyskinesia (abnormality or impairment of voluntary movement)
  3. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  4. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  5. Nausea (feeling of having an urge to vomit)
  6. Pain
  7. Restless legs syndrome (a powerful urge to move your legs)
  8. Sluggishness (lacking alertness)
  9. Suicidal ideation
  10. Drug ineffective

What are the common drug interactions of Abilify and Coq, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Impulse-control disorder
  2. Insomnia (sleeplessness)
  3. Poverty of speech
  4. Quality of life decreased
  5. Restlessness (not able to rest)
  6. Theft

30-39:

  1. Insomnia (sleeplessness)
  2. Nausea (feeling of having an urge to vomit)

40-49:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Altered state of consciousness (altered state of mind)
  3. Aphasia (damage to the parts of the brain that control language)
  4. Blood pressure diastolic increased
  5. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Chest pain
  8. Corneal dystrophy (abnormal deposition of substances in the transparent front part of the eye)
  9. Dysarthria (speech disorder)
  10. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Incoherent (talking in a confused and unclear way)
  2. Infection
  3. Influenza
  4. Libido increased (increased sexual urge to have sex)
  5. Limb injury
  6. Memory impairment
  7. Muscle rupture (tear in muscle)
  8. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  9. Myalgia (muscle pain)
  10. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Pain in extremity
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Knee arthroplasty
  5. Spinal cord compression
  6. Adverse event
  7. Blood pressure decreased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cardiac arrest
  10. Chest discomfort

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 15 people, 24.19%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 17.74%
  3. Pain: 4 people, 6.45%
  4. Insomnia (sleeplessness): 4 people, 6.45%
  5. High Blood Pressure: 4 people, 6.45%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 6.45%
  7. Bipolar Disorder (mood disorder): 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Coq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Coq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Coq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and coenzyme q - 10 (the active ingredients of Abilify and Coq, respectively), and Abilify and Coq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: